For healthcare providers seeking to optimize urological care, reduce catheter-associated infections (CAUTI), and enhance patient comfort, Verathon BladderScan BVI 9400 delivers a breakthrough solution. This portable, non-invasive bladder volume measurement device uses patented NeuralHarmonics® technology to generate 3D bladder images and calculate urine volume within seconds—transforming clinical workflows in urology, oncology, and acute care settings.
Why Bladder Volume Accuracy Matters in Modern Medicine
In pelvic cancer radiotherapy, consistent bladder volume during treatment significantly impacts outcomes. Studies show that with a full bladder:
- Rectal cancer patients experience a 24.8% reduction in bladder radiation dose and 46.6% lower small bowel exposure.
- Prostate cancer patients see bladder radiation doses drop to 35% of empty-bladder levels.
The BVI 9400 ensures bladder volume aligns with simulation scans, minimizing organ damage and improving precision.
Key Clinical Advantages of BladderScan BVI 9400
- Unmatched Accuracy and Speed:
- Measures volumes from 0–999 mL with ±15% or ±15 mL accuracy.
- Completes scans in <3 seconds, displaying results instantly on its intuitive interface.
- Strong correlation (R=0.96) with gold-standard ultrasound systems like iU22, with accuracy improving at larger volumes.
- CAUTI Reduction and Enhanced Patient Safety:
- Reduces unnecessary catheterizations by 87% and re-catheterization rates by 80% in post-surgical urinary retention cases.
- Enables personalized bladder care protocols, like targeted intermittent catheterization when volumes exceed 300mL.
- User-Friendly Design for Broad Adoption:
- Weighs only 2.36 kg with a handheld probe and simple three-step operation: apply gel, aim, scan.
- Includes gender-specific modes (male, female, child) and real-time aiming guidance via an on-screen targeting icon.
Table: BladderScan BVI 9400 vs. Traditional Volume Assessment Methods
| Feature | BladderScan BVI 9400 | Traditional Ultrasound | Palpation/Percussion |
|---|---|---|---|
| Accuracy | ±15% / ±15 mL | ±30% / ±30 mL | Low (operator-dependent) |
| Scan Time | <3 seconds | 5–10 minutes | N/A |
| 3D Imaging | Yes | No | No |
| Training Required | Minimal (non-specialist) | Extensive | Moderate |
| Portability | Handheld, battery-operated | Cart-based, fixed | N/A |
| CAUTI Risk Reduction | Yes (evidence-based) | Limited | No |
| Patient Comfort | High (non-invasive) | Moderate | Low |
Transforming Clinical Workflows
- Oncology: Monitors bladder filling during pelvic radiation, protecting organs and ensuring treatment reproducibility.
- Post-Surgical Care: Guides urinary retention management in 39% of surgical patients unable to void spontaneously.
- ICU/Chronic Care: Facilitates timed voiding or catheterization, reducing infection risks and preserving renal function.
The Verathon Advantage
Since its 2013 launch in China, the BVI 9400 has become a global standard—used in 500+ U.S. hospitals and 40+ Hong Kong facilities47. Its HIPAA-compatible ScanPoint® software enables wireless data transfer for EHR integration, report printing, and trend analysis.
Conclusion
The BladderScan BVI 9400 isn’t just a tool—it’s a paradigm shift toward precision bladder management. By replacing guesswork with quantifiable metrics, it elevates patient safety, slashes CAUTI rates, and streamlines resource use. As pelvic radiotherapy and value-based care expand, this technology is becoming indispensable.